Pulmonx Corporation gains attention as healthcare strength highlights its emphysema-focused Zephyr Valve and Chartis patient ...
Lung transplant for stage IV lung cancer achieved 100% one-year survival in 17 NSCLC patients in a landmark JAMA study from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results